The CEO of Bavarian Nordic expects increased U.S. biodefense funding, which is positive for the company. However, the nomination of Robert F. Kennedy Jr. could lead to vaccine skepticism, potentially impacting the company's vaccine-related business. Overall, the anticipated funding boost is likely to have a positive short-term impact on the stock.